CTRI/2017/08/009443Not Applicable未知
Intravitreal Clindamycin and Dexamesathzone with or without systemic anti toxoplasmosis in the management of toxoplasma chorio-retinitis
il0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- Not Applicable
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients with active toxoplasma chorioretinitis
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Exploratory study of intravitreal clindamycin and dexamethasone in the treatment of acute toxoplasma chorioretinitis associated vitritis - intravitreal clindamycin and dexamethasone for toxoplasma vitritisEUCTR2006-005008-15-GBMoorfields Eye Hospital NHS Foundation Trust10
已完成
不适用
Intravitreal dexamethasone treatment of bacterial endophthalmitisPost-operative bacterial endophthalmitisEye DiseasesDisorders of globeISRCTN77234772Rotterdam Eye Hospital (Oogziekenhuis Rotterdam) (The Netherlands)150
已完成
不适用
Intravitreal Dexamethason treatment of bacterial endophthalmitis.EndophthalmitisNL-OMON28649Het Oogziekenhuis Rotterdam150
Unknown
3 期
To Compare Intravitreal Clindamycin & Dexamethasone With Classic Treatment of Toxoplasmic RetinochoroiditisChorioretinitisNCT00372294Shahid Beheshti University of Medical Sciences
已完成
3 期
Intravitreal dexamethasone for resistant wet-AMDResistent choroidal neovascularizationWet aged macular degenerationACTRN12618001102268A.O.U. Sassari20